Two companies are conducting trials to develop a dengue vaccine, says DG ICMR, Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com

According to the vaccine trials status, Panacea has done phase l/ll and the trials have been completed on 100 adults between the ages of 18 and 60 years., According to the vaccine trials status, Panacea has done phase l/ll and the trials have been completed on 100 adults between the ages of 18 and 60 years., , Read More

Leave a Reply

Your email address will not be published.